ROS-responsive biomimetic nanosystem camouflaged by hybrid membranes of platelet-exosomes engineered with neuronal targeting peptide for TBI therapy
Journal of Controlled Release · 2024-08 · 372 · 531-550
DOI: 10.1016/j.jconrel.2024.06.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2024-08. Verfasst von Yi Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Institute of Pharmacology and Toxicology, Beijing 100850, People's Republic of China. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Neurons, Reactive Oxygen Species, Blood Platelets. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation.
Abstract (Originalsprache)
Recovery and survival following traumatic brain injury (TBI) depends on optimal amelioration of secondary injuries at lesion site. Delivering mitochondria-protecting drugs to neurons may revive damaged neurons at sites secondarily traumatized by TBI. Pioglitazone (PGZ) is a promising candidate for TBI treatment, limited by its low brain accumulation and poor targetability to neurons. Herein, we report a ROS-responsive nanosystem, camouflaged by hybrid membranes of platelets and engineered extracellular vesicles (EVs) (C3-EPm-|TKNPs|), that can be used for targeted delivery of PGZ for TBI therapy. Inspired by intrinsic ability of macrophages for inflammatory chemotaxis, engineered M2-like macrophage-derived EVs were constructed by fusing C3 peptide to EVs membrane integrator protein, Lamp2b, to confer them with ability to target neurons in inflamed lesions. Platelets provided hybridized EPm with capabilities to target hemorrhagic area caused by trauma via surface proteins. Consequently, C3-EPm-|PGZ-TKNPs| were orientedly delivered to neurons located in the traumatized hemisphere after intravenous administration, and triggered the release of PGZ from TKNPs via oxidative stress. The current work demonstrate that C3-EPm-|TKNPs| can effectively deliver PGZ to alleviate mitochondrial damage via mitoNEET for neuroprotection, further reversing behavioral deficits in TBI mice. Our findings provide proof-of-concept evidence of C3-EPm-|TKNPs|-derived nanodrugs as potential clinical approaches against neuroinflammation-related intracranial diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Institute of Pharmacology and Toxicology, Beijing 100850, People's Republic of China.
- Beijing Institute of Pharmacology and Toxicology, Beijing 100850, People's Republic of China; College of Pharmacy, Henan University, Kaifeng 475000, People's Republic of China.
- Beijing Institute of Pharmacology and Toxicology, Beijing 100850, People's Republic of China; School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China.
- School of Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China. Electronic address: hy_syphu@163.com.
- Beijing Institute of Pharmacology and Toxicology, Beijing 100850, People's Republic of China. Electronic address: gaocs@bmi.ac.cn.
- Beijing Institute of Pharmacology and Toxicology, Beijing 100850, People's Republic of China. Electronic address: amms2013@126.com.
Förderung
- National Natural Science Foundation of China
- Beijing Natural Science Foundation
Zitieren
APA
Li, Y., Xin, X., Zhou, X., Liu, J., Liu, H., Yuan, S., Liu, H., Hao, W., Sun, J., Wang, Y., Gong, W., Yang, M., Li, Z., Han, Y., Gao, C., & Yang, Y. (2024). ROS-responsive biomimetic nanosystem camouflaged by hybrid membranes of platelet-exosomes engineered with neuronal targeting peptide for TBI therapy. Journal of Controlled Release, 372, 531-550. https://doi.org/10.1016/j.jconrel.2024.06.018
Vancouver
Li Y, Xin X, Zhou X, Liu J, Liu H, Yuan S, et al. ROS-responsive biomimetic nanosystem camouflaged by hybrid membranes of platelet-exosomes engineered with neuronal targeting peptide for TBI therapy. Journal of Controlled Release. 2024;372:531-550. doi:10.1016/j.jconrel.2024.06.018
BibTeX
@article{Li2024,
author = {Li, Yi and Xin, Xin and Zhou, Xun and Liu, Jingzhou and Liu, Hangbing and Yuan, Shuo and Liu, Hanhan and Hao, Wenyan and Sun, Jiejie and Wang, Yuli and Gong, Wei and Yang, Meiyan and Li, Zhiping and Han, Yang and Gao, Chunsheng and Yang, Yang},
title = {ROS-responsive biomimetic nanosystem camouflaged by hybrid membranes of platelet-exosomes engineered with neuronal targeting peptide for TBI therapy},
journal = {Journal of Controlled Release},
year = {2024},
volume = {372},
pages = {531--550},
doi = {10.1016/j.jconrel.2024.06.018}
}
EUVIMED